5-fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a19F-nuclear magnetic resonance spectroscopy study in vivo

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 3, 1995, Pages 259-265

  Tausch Treml, Robert ^a   Baumgart, Frank ^b   Ziessow, Dieter ^b   Köpf Maier, Petra ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

5 FU; 19F NMR spectroscopy; Combined treatment modality

Indexed keywords

FLUORINE; FLUOROURACIL; METHOTREXATE; THYMIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG METABOLISM; HUMAN; HUMAN CELL; HYPOPHARYNX CARCINOMA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMAL; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA; COLONIC NEOPLASMS; FLUORINE RADIOISOTOPES; FLUOROURACIL; HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; METHOTREXATE; MICE; MICE, NUDE; PHARYNGEAL NEOPLASMS; SUPPORT, NON-U.S. GOV'T; THYMIDINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029655613     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00688326     Document Type: Article

References (25)

1. Optimal scheduling of methotrexate and 5-fluorouracil in human breast cancer
2. Effects of thymidine on deoxyribonucleotide triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells
3. A basis for pyrimidineinduced antagonism to methotrexate in Ehrlich ascites tumour cells in vitro
4. Clinical applications of the concept of methotrexate plus 5-FU sequence-dependent “synergy”. How good is the evidence?
5. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells
6. Enhancement of 5-fluorouracil anti-tumor effects by the prior administration of methotrexate
7. In vivo19F NMR spectroscopy: a potential monitor of 5-fluourouracil pharmacokinetics and metabolism
8. Fluorinated pyrimidines
9. Metabolites of 5-fluorouracil in plasma and urine as monitored by19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pre-treatment
10. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells
11. In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by19F NMR spectroscopy
12. Phase I evaluation and pharmacokinetic study of weekly i. v. thymidine or 5-FU in patients with advanced colorectal carcinoma
13. Fluorouracil: biochemistry and pharmacology
14. Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo
15. Detection of differential sensitivity to 5-fluorouracil in Ehrlich ascites tumour cells by19F NMR spectroscopy
16. Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a19F-MRS study in vivo
17. Enzymes of uracil catabolism in normal and neoplastic human tissues
18. Nucleoside and nucleobase transport in animal cells
19. Thymidine modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by19F magnetic resonance spectroscopy
20. 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumours and liver
21. Potentiation of the anti-tumor activity of 5-FU by thymidine and its correlation with the formation of (5FU)RNA
22. 31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin: comparison of three sublines with increasing resistance
23. 31P NMR spectroscopy of a xenografted hypopharynx carcinoma: effects of tumour growth and treatment with cisplatin on the tumour phosphorus metabolism, histology and cytokinetics
24. Cytotoxicity of 5-fluoro-2-deoxuridine: requirement for reduced folate cofactors and antagonism by methotrexate
25. Combination clinical trials with thymidine and 5-fluorouracil: a phase I and clinical pharmacological evaluation